Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2026-08-17 16:32:42 ET · period of report 2026-08-14 · accession 0001434647-26-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-17 16:32 | 2026-08-14 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | S - Sale | $11.13 | -42.7K | 37.6K | -53% | -$474.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | S | D | 42,666 | $11.13 | 37,569 | D | — | — | (F1) Adoption date of referenced 10b5-1(c) plan is: 05-15-2026 (F2) This transaction was executed in multiple trades at prices ranging from $10.86 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |